Accuray Incorporated (ARAY) News

RECEIVED FDA CLEARANCE!

Accuray Inc NASDAQ: ARAY

GoSymbol lookup
Health Care : Health Care Equipment & Supplies | Small Cap BlendCompany profile
Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells, and supports solutions that are designed to deliver radiation treatments. Its solutions are designed to advance patient care during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, the Company also provides services, which include post-contract customer support (warranty period services and post warranty services), installation services, training, and other professional services.
New 52 week high
Accuray Inc NASDAQ: ARAY

GoSymbol lookup
Health Care : Health Care Equipment & Supplies | Small Cap BlendCompany profile
Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells, and supports solutions that are designed to deliver radiation treatments. Its solutions are designed to advance patient care during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, the Company also provides services, which include post-contract customer support (warranty period services and post warranty services), installation services, training, and other professional services.
New 52 week high

Accuray Inc NASDAQ: ARAY

GoSymbol lookup
Health Care : Health Care Equipment & Supplies | Small Cap BlendCompany profile
Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells, and supports solutions that are designed to deliver radiation treatments. Its solutions are designed to advance patient care during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, the Company also provides services, which include post-contract customer support (warranty period services and post warranty services), installation services, training, and other professional services.
New 52 week high

Aray comes out with earnings and still no one post on this board. What is everyone doing that keeps you off this board?

You asked where everyone went... Check out the boards for RDGL

Not sure what the meaning of your message is.

RDGL / Vivos

Wow, last post on here 02/2021. Where is everyone?

ACCURAY INC: WHITTERS JOSEPH E (Director) Buys 20,000 @ Avg Price: $5.02 (Form4)

First Quarter Fiscal 2021 Summary

Net revenue of $85.3 million, operating income of $5.5 million
Adjusted EBITDA grew to $9 million from a loss of $1 million in the prior year first quarter
Gross orders of $50.5 million, ending backlog of $597.3 million, an increase of 21 percent from September 30, 2019

Other Recent Operational Highlights

Expect revenue recognition for China Type A systems previously awarded in October 2019 to start in the second quarter of fiscal 2021
Introduced ClearRT™ Helical kVCT Imaging for the Radixact System at ASTRO 2020
44 clinical abstracts related to customer clinical experience on CyberKnife and TomoTherapy/Radixact exhibited at ASTRO 2020 Scientific Sessions

"We are off to a solid start in fiscal 2021 despite the headwinds created by the COVID-19 environment. Our global team continues to adapt and make the necessary adjustments to compete and operate effectively given the current market conditions and delivered the fourth consecutive quarter of operating profit, said Joshua H. Levine, President and CEO of Accuray. "Looking ahead, we will be focused on driving the revenue conversion process related to the China Type A systems beginning in the second quarter. Concurrent with this year's recent ASTRO meeting, we have received very positive customer feedback related to the introduction of our ClearRT™ Helical kVCT imaging upgrade for the Radixact System as we drive our long-term strategic commitment to continued innovation."

Q1 Fiscal 2021 Financial Highlights

Gross product orders totaled $50.5 million for the first quarter of fiscal 2021 compared to $78.5 million for the prior fiscal year first quarter. Order backlog as of September 30, 2020 was $597.3 million, approximately 21 percent higher than at the end of the prior fiscal year first quarter.

Total net revenue was $85.3 million for the first quarter of fiscal 2021 compared to $89.6 million for the prior fiscal year first quarter. Product revenue totaled $31.3 million for the first quarter of fiscal 2021 compared to $37.6 million for the prior fiscal year first quarter, while service revenue totaled $54.1 million for the first quarter of fiscal 2021 compared to $52.0 million for the prior fiscal year first quarter.

Total gross profit for the first quarter of fiscal 2021 was $35.4 million or approximately 41.5 percent of total net revenue, comprised of product gross margin of 41.1 percent of product net revenue and service gross margin of 41.7 percent of service net revenue. This compares to total gross profit of $32.9 million or 36.8 percent of total net revenue, comprised of product gross margin of 42.6 percent of product net revenue and service gross margin of 32.5 percent of service net revenue for the prior fiscal year first quarter.

Net income was $0.4 million, or $0.0 per share, for the first quarter of fiscal 2021, compared to a net loss of $9.4 million, or a loss of $0.11 per share, for the prior fiscal year first quarter.

Adjusted EBITDA for the first quarter of fiscal 2021 was a positive $9.0 million, compared to a negative $1.0 million for the prior fiscal year first quarter.

Cash, cash equivalents, and short-term restricted cash were $95.5 million as of September 30, 2020, a decrease of $13.1 million from June 30, 2020 primarily due to a $10 million prepayment in principal with respect to our long-term debt.

Financial Guidance

The impact of the COVID-19 pandemic on Accuray's fiscal 2021 results remains uncertain. Given the continued evolution of the COVID-19 pandemic and the uncertainty surrounding its impact on the global economy and the healthcare industry, Accuray believes it is prudent to refrain from providing financial guidance for fiscal year 2021.

On October 26, 2020, Accuray Incorporated (the “Company”) will be hosting an Analyst & Investor Virtual Meeting (the “Investor Meeting”) in conjunction with the American Society of Radiation Oncology (ASTRO) Annual Meeting. The Investor Meeting will take place virtually and begin at 1:00pm ET (10:00am PT) and can be viewed live at https://www.accuray.com/investor-day-2020-rsvp/. A replay of the webcast will be available on the investor relations portion of the Company’s website within 24 hours of the conclusion of the presentation.

CMS 'pouring fuel on the fire' for Accuray with APM rule, says Lake Street 09:18 ARAY Lake Street analyst Brooks O'Neil said he believes Accuray is "exceptionally well-positioned to win" as healthcare markets globally stabilize after the COVID-19 pandemic, adding that CMS "is pouring fuel on the fire" by publishing a final rule related to an Alternate Payment Model now set to begin in 30% of the U.S. on January 1, 2021. The CMS rule will reward providers who utilize the high intensity, low frequency treatments pioneered by Accuray, according to O'Neil, who also sees the company as "on the cusp of the incredible opportunity to begin to deliver both Type A and Type B equipment to the massive China market over the next several quarters." O'Neil keeps a Buy rating and $10 price target on Accuray shares.

Read more at:
https://thefly.com/n.php?id=3166628

This was from Monday 9/28/20

big block at 2.46, now 2.55

* * $ARAY Video Chart 01-30-2020 * *

Link to Video - click here to watch the technical chart video

* * $ARAY Video Chart 01-22-2020 * *

Link to Video - click here to watch the technical chart video

* * $ARAY Video Chart 01-21-2020 * *

Link to Video - click here to watch the technical chart video

News: $ARAY Accuray To Report Fiscal 2019 Fourth Quarter and Full Year Financial Results on August 15, 2019

SUNNYVALE, Calif. , July 19, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its fourth quarter and fiscal year 2019 ended June 30, 2019 on Thursday, August 15, 2019 after the market close. Management will host a conference call to review the res...

Read the whole news Accuray To Report Fiscal 2019 Fourth Quarter and Full Year Financial Results on August 15, 2019

News: $ARAY Accuray Launches Synchrony® Motion Tracking and Correction Technology for the Radixact® System

SUNNYVALE, Calif. , April 24, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the launch of its Synchrony ® motion tracking and correction technology 1  to be used with the Radixact ® System . This new feature adds intrafraction motion synch...

In case you are interested https://marketwirenews.com/news-releases/accuray-launches-synchrony-xae-motion-tracking-and-correction-technology-for-the-radixact-xae-system-8048882.html

* * $ARAY Video Chart 01-23-2019 * *

Link to Video - click here to watch the technical chart video

* * $ARAY Video Chart 10-31-18 * *

Link to Video - click here to watch the technical chart video

Huge News! "Mercy Advances Cancer Care in Missouri with Multi-System, Multi-Hospital Agreement for Accuray Radiation Therapy Systems". It is clear ARAY is the real deal! They have gained traction. Great public reference from the customer thereby arming their sales force. I would bet and am betting the sales pipeline is large and they are in the close cycle on many deals. This news will push many new customers to sign on the dotted line. You can not overestimate the significance of this news. It will translate to $$$.

* * $ARAY Video Chart 05-01-18 * *

Link to Video - click here to watch the technical chart video

This finding would seem support radio therapy and especially radio surgery (CyberKnife) as a more viable (as well as much less invasive) option to actual surgery as the preferred treatment protocol. Problem: Physicians fees for radio surgery are much less than for actual surgery. What do you think this means in terms of physician referrals and treatment advice? Exactly.

https://www.usatoday.com/story/news/2018/04/11/breast-cancer-surgery-healing-study/506525002/

This finding would seem support radio therapy and especially radio surgery (CyberKnife) as a more viable (as well as much less invasive) option to actual surgery as the preferred treatment protocol. Problem: Physicians fees for radio surgery are much less than for actual surgery. What do you think this means in terms of physician referrals and treatment advice? Exactly.

https://www.usatoday.com/story/news/2018/04/11/breast-cancer-surgery-healing-study/506525002/

Excellent earnings report. Looking for a big move by ARAY. JMO

ARAY big earnings news!
Accuray Fiscal Second Quarter Revenue Exceeds $100 Million and Increases 15 Percent Year-over-Year; Gross Orders of $77.9 Mil...

ARAY bullish 5.31

nasdaq stocks $1-10 with volume > 100,000

$ARAY recent news/filings

bullish 7.03
bull flag continuation
moving average support
moving average breakout

## source: finance.yahoo.com

Fri, 27 Nov 2015 12:03:55 GMT ~ Is Accuray Incorporated (ARAY) a Good Buy?


read full: http://www.insidermonkey.com/blog/is-accuray-incorporated-aray-a-good-buy-390968/
*********************************************************

Sat, 21 Nov 2015 18:25:37 GMT ~ Healthways, Inc. (HWAY): Are Hedge Funds Right To Leave This Stock?


read full: http://www.insidermonkey.com/blog/healthways-inc-hway-are-hedge-funds-right-to-leave-this-stock-385630/
*********************************************************

Fri, 20 Nov 2015 21:06:30 GMT ~ ACCURAY INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders


read full: http://biz.yahoo.com/e/151120/aray8-k.html
*********************************************************

Mon, 16 Nov 2015 21:32:00 GMT ~ SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of Fiduciary Duty by the Board of Accuray Incorporated

[Accesswire] - NEW YORK, NY / ACCESSWIRE / November 16, 2015 / Levi & Korsinsky announces it has commenced an investigation of Accuray Incorporated (NASDAQGS: ARAY) concerning possible breaches of fiduciary duty by the ...

read full: http://finance.yahoo.com/news/shareholder-alert-levi-korsinsky-llp-213200757.html
*********************************************************

Fri, 13 Nov 2015 18:04:17 GMT ~ ACCURAY INC Financials


read full: http://finance.yahoo.com/q/is?s=aray
*********************************************************

$ARAY charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com



$ARAY company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/ARAY/company-info
Ticker: $ARAY
OTC Market Place: Not Available
CIK code: 0001138723
Company name: Accuray, Inc.
Incorporated In: DE, USA


$ARAY share structure

## source: otcmarkets.com

Market Value: $561,485,784 a/o Nov 27, 2015
Shares Outstanding: 79,869,955 a/o Oct 28, 2015
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value

$ARAY extra dd links

Company name: Accuray, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/ARAY/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/ARAY/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=ARAY+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=ARAY+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=ARAY+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/ARAY/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/ARAY/news - http://finance.yahoo.com/q/h?s=ARAY+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/ARAY/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/ARAY/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/ARAY/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/ARAY/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/ARAY/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/ARAY/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/ARAY/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/ARAY/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=ARAY+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/ARAY
DTCC (dtcc.com): http://search2.dtcc.com/?q=Accuray%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Accuray%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Accuray%2C+Inc.&x=0&y=0

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/ARAY/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/ARAY
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/ARAY/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/ARAY/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/ARAY/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001138723&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/ARAY/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/ARAY/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/ARAY/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/ARAY/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=ARAY&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=ARAY
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/ARAY/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=ARAY+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=ARAY+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=ARAY
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=ARAY
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=ARAY+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/ARAY/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=ARAY+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/ARAY.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=ARAY
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/ARAY/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/ARAY/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/ARAY/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/ARAY/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/ARAY
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/ARAY
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/ARAY:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=ARAY
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=ARAY



$ARAY DD Notes ~ http://www.ddnotesmaker.com/ARAY

Gap fill would be nice!!!! :)

Show time! Would like to see $9.5 by cristmass

$ARAY recent news/filings

bearish daytrade

## source: finance.yahoo.com

Mon, 11 May 2015 00:11:51 GMT ~ 10-Q for Accuray, Inc.


read full: http://www.companyspotlight.com/routers/headline/18143/10004/6514368?cp_code=YAH1&1431303111
*********************************************************

Thu, 07 May 2015 10:09:36 GMT ~ ACCURAY INC Files SEC form 10-Q, Quarterly Report


read full: http://biz.yahoo.com/e/150507/aray10-q.html
*********************************************************

Tue, 05 May 2015 17:40:05 GMT ~ Accuray Q3 Loss Narrower than Expected, Revenues Lag - Analyst Blog


read full: http://finance.yahoo.com/news/accuray-q3-loss-narrower-expected-174005306.html
*********************************************************

Tue, 05 May 2015 13:00:00 GMT ~ Accuray to Participate in the Bank of America Merrill Lynch 2015 Healthcare Conference

[PR Newswire] - A live webcast of the presentation will be available on the Investor Relations page of the Company's website at http://www.accuray.com/investors. The webcast replay of the presentation will begin approximately one hour after the conclusion of the live presentation and will be available for approximately 30 days.

read full: http://finance.yahoo.com/news/accuray-participate-bank-america-merrill-130000619.html
*********************************************************

Thu, 30 Apr 2015 22:36:19 GMT ~ Accuray slides in late trading after cutting revenue outlook


read full: http://sg.finance.yahoo.com/news/accuray-slides-trading-cutting-revenue-223619060.html
*********************************************************

$ARAY charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com



$ARAY company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/ARAY/company-info
Ticker: $ARAY
OTC Market Place: Not Available
CIK code: 0001138723
Company name: Accuray, Inc.
Incorporated In: CA, USA



$ARAY share structure

## source: otcmarkets.com

Market Value: $485,849,250 a/o May 13, 2015
Shares Outstanding: 78,489,378 a/o Jan 30, 2015
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value

$ARAY extra dd links

Company name: Accuray, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/ARAY/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/ARAY/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=ARAY+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=ARAY+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=ARAY+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/ARAY/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/ARAY/news - http://finance.yahoo.com/q/h?s=ARAY+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/ARAY/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/ARAY/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/ARAY/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/ARAY/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/ARAY/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/ARAY/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/ARAY/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/ARAY/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=ARAY+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/ARAY
DTCC (dtcc.com): http://search2.dtcc.com/?q=Accuray%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Accuray%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Accuray%2C+Inc.&x=0&y=0

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/ARAY/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/ARAY
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/ARAY/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/ARAY/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/ARAY/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001138723&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/ARAY/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/ARAY/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/ARAY/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/ARAY/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=ARAY&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=ARAY
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/ARAY/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=ARAY+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=ARAY+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=ARAY
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=ARAY
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=ARAY+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/ARAY/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=ARAY+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/ARAY.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=ARAY
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/ARAY/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/ARAY/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/ARAY/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/ARAY/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/ARAY
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/ARAY
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/ARAY:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=ARAY
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=ARAY



$ARAY DD Notes ~ http://www.ddnotesmaker.com/ARAY

Hey grant!
not been on here in a while sorry buddy and onvo.. your welcome and blinkx reports Tuesday and I will look at that new stock you gave me! hope all is well..

Accuray rises premarket as 4Q orders improve
Accuray rises after company says radiation therapy system orders got better in 4th quarter

Associated PressAssociated Press – 1 hour 15 minutes ago

NEW YORK (AP) -- Shares of Accuray climbed in premarket trading Wednesday after the radiation-treatment equipment maker said new orders are improving.
Accuray reported its fiscal fourth-quarter results after the market closed on Tuesday. Its loss narrowed from a year ago despite a decline in revenue. Net new product orders rose 32 percent from last year, and the company said its backlog has grown over the last three months and is larger than it was a year ago.
Accuray shares picked up 50 cents, or 8.2 percent, to $6.60 in premarket trading.
The Sunnyvale, Calif., company sells radiation therapy systems under the names CyberKnife and TomoTherapy. Accuray said it took a loss of $18.7 million, or 25 cents per share, over the three months ended June 30. Accuray Inc. took a loss of $20.3 million, or 28 cents per share, a year earlier.
If one-time items are excluded the company said it lost 20 cents per share in the fourth quarters of fiscal 2013 and 2012. Revenue fell 16 percent, to $84.9 million from $100.5 million.
Analysts were expecting a loss of 20 cents per share on $84.3 million in revenue, according to FactSet.
Jefferies & Co. analyst Raj Denhoy said Accuray is moving in the right direction because orders are increasing and the company is getting better at keeping its costs under control. He kept a "Buy" rating on the stock and raised his price target to $8 per share from $6.50.
Accuray said it lost $103.2 million, or $1.41 per share, in fiscal 2013 after losing $72 million, or $1.02 per share, the year before. Revenue fell 23 percent, to $316 million from $409.2 million.
The company expects to report $325 million to $345 million in revenue in fiscal 2014. Analysts estimate $359.6 million on average.

~ $ARAY ~ Daily Par Sar Buy Signal ~ Criteria alert triggered during a recent trading session!

$ARAY has just triggered the "Parabolic SAR Buy Signals" scan criteria at Stockcharts.com
~ http://tinyurl.com/SAR-BUY ~







For a more in Depth study and DD profile, similar to the one contained in this link: ~ http://tinyurl.com/DDexample ~
Click the following link and type ticker or brief message asking me about the DD: ~ http://tinyurl.com/GET-THE-DD ~

What does the scan "Parabolic SAR Buy Signals" mean? Below is an image example and study link.
~ http://stockcharts.com/school/doku.php?id=chart_school:technical_indicators:parabolic_sar ~


To find other similar posts of "ARAY" utilize the links that follow.
Search MACDgyver's "Parabolic SAR Buy Signals" posts: ~ http://investorshub.advfn.com/boards/msgsearchbymember.aspx?searchID=251916&srchyr=2013&SearchStr=ParSarBuyScan ~
Search MACDgyver's posts for symbol "ARAY": ~ http://investorshub.advfn.com/boards/msgsearchbymember.aspx?searchID=251916&srchyr=2013&SearchStr=ARAY ~
Search Ihub for "ARAY" posts: ~ http://investorshub.advfn.com/boards/msgsearch.aspx?SearchStr=ARAY ~


For more in depth training and information visit Chartschool on the Stockcharts page.
~ http://stockcharts.com/school/doku.php?id=chart_school ~


Also don't forget the Ihub Edu Channel.
~ http://investorshub.advfn.com/boards/education.aspx ~


c

7:02AM Accuray provides clarification on recently initiated voluntary recalls; no known injuries have been reported to date (ARAY) 4.44 : Co has voluntarily implemented a recall of two separate components from its CyberKnife product line: the Iris Variable Aperture Collimator and the RoboCouch Patient Positioning System. The affected parts are manufactured by third-party suppliers and are being removed from the system because they failed to meet the company's specifications and standards for quality. The co has notified impacted customers, and field service personnel have been deployed to apply the corrections should they be necessary. These recalls exclude the CyberKnife M6 Series Series. "We are pleased to report that no known injuries have been reported to date as a result of these issues."

5:11AM Accuray prices $100 mln of 3.50% convertible senior notes due 2018 (ARAY) 4.44 :

thanks... will take a look...

cheers,
grant

grant,
I found a new stock that you may like ONVO it is a 3-d bio printing stock trying to print tissues for drug companies for drug testing and also print body organs such as heart liver kidneys and even teeth!
On the pink sheets with a goal of NASDAQ listing and i seen an article saying it could be bigger than apple someday.
check it out!

the what??? & why might I be expected to know that?

Grant I am disappointed in ARAY's mgnt. team as well if they concentrated more on us investors than their own pockets then they would be some of the richest people in the world with stock options..
I gave up not bc of their great tech but bc of mgnt. you need a great product with a top mgnt. team i don't see these guys getting the job done sorry to say.
I hope the best for you tho.
as for cancer aray sure beats chemo hands down if one can afford its fees!
no doubt about that period!

Were the ENSSFM involved in this?

ARAY has surely been disappointing... I am astonished at the management disregard for shareholders over the years. I think the technology has failed to achieve the market dominance it appeared that it would achieve... it may now have lost the edge since the acquiring of TOMO.

I had hoped it would be my next "ISRG" bought into much lower than my 90-100 basis level with ISRG. Hindsight being perfect allows me to sigh and say "at least I did buy shares of ISRG when I could... just not the thousands of shares I'd have liked to have!" LOL

So I have no regrets with ARAY... a little wasted time... a lot of work trying to flip shares to get down to "even" as opportunities allowed... and now I just have to decide IF I will hold it for much longer. My wife has wanted to dump it for some time... so I told her to go ahead last time it ran past 7. She still wants me to sell the remaining shares I have in my account.

ARAY's Cyberknife continues to be MY TREATMENT of CHOICE should I ever have a cancer that has an effective protocol.

hi grant,
After years of waiting on ARAY stock to do something I sold most of my ARAY shares to buy into SZYM which is a bio fuel with some huge partners for oil..a company called solazyme.

8:41AM Accuray: Presentations at radiation oncology meeting highlight CyberKnife prostate outcomes from patients at more than 40 centers (ARAY) 6.91 : Co announced today clinical findings using non-invasive CyberKnife? stereotactic body radiation therapy for the treatment of prostate cancer. Two studies presented at the 54th Annual American Society for Radiation Oncology (ASTRO) Meeting in Boston were selected by ASTRO for presentation to the media at a prostate-focused press conference on Tuesday, October 30, 2012, for which the use of CyberKnife SBRT for prostate cancer represented half of the press conference's focus. Patients were followed for a median of 36 months, and close to half were followed for at least four years, as updated by Dr. Katz during his presentation. Actuarial five-year disease-free survival was 95 percent for low-risk patients, 90 percent for intermediate-risk patients and 80 percent for high-risk patients. These findings compare favorably with other surgical and radiation-based treatments

8:32AM Accuray receives FDA 510(k) clearance for new CyberKnife M6 series (ARAY) 6.96 : Co announced that the company received 510(k) clearance from the FDA for its new CyberKnife M6 Series. The CyberKnife M6 Series features expanded clinical capabilities, reduced treatment times and an enhanced patient experience.

7:03AM Accuray CEO resigns, Board appoints Joshua H. Levine as his successor as President and CEO and Director of the Board, effective immediately (ARAY) 7.02 : Co announced that Euan S. Thomson has resigned as President and Chief Executive Officer and Director of the Board. Accuray's Board has appointed Joshua H. Levine as his successor as President and CEO and Director of the Board, effective immediately. Thomson is anticipated to continue in a consulting role with the Company. Levine recently was CEO of Immucor Corporation until October 2011 when it was acquired by TPG Capital.

Accuray Incorporated to Host Investor Meeting at ASTRO 2012
PR NewswirePress Release: Accuray Incorporated – Mon, Oct 1, 2012 8:30 AM EDT

SUNNYVALE, Calif., Oct. 1, 2012 /PRNewswire/ -- Accuray Incorporated (ARAY), the premier radiation oncology company, announced today that it will host an investor meeting on Monday, October 29, 2012 at the annual meeting of the American Society for Radiation Oncology (ASTRO) being held in Boston. The meeting is open to institutional investors and research analysts.

Accuray's management will host a breakfast meeting, from 7:30 a.m. to 9:30 a.m. E.D.T. on Monday, October 29 at the Renaissance Boston Waterfront Hotel, 606 Congress Street Boston, in the Pacific Ballroom, Salon A-C. The presentation will provide a review of Accuray's new technology platforms that will be introduced at ASTRO. Investors who are attending the trade show are encouraged to visit the Accuray booth #7101.

Attendees are asked to register no later than Friday, October 19 from our event website: http://www.cvent.com/d/bcqxrm.

A live webcast of the presentation will be available online from the investor relations section of the company website at www.accuray.com/investors. The webcast replay of the presentation will begin approximately one hour after the conclusion of the live presentation and will be available for approximately 30 days.

About Accuray
Accuray Incorporated (ARAY), based in Sunnyvale, Calif., is the premier radiation oncology company that develops, manufactures and sells personalized, innovative treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. The Company's leading-edge technologies – the CyberKnife and TomoTherapy Systems – are designed to deliver radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image guided radiation therapy, and adaptive radiation therapy. To date, 642 systems have been installed in leading hospitals around the world. For more information, please visit www.accuray.com.

Available Topic Expert: For information on the listed expert, click appropriate link.
Euan Thomson, Ph.D.
ProfNet - https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=81869

8:31AM Accuray signed a definitive agreement to acquire Morphormics, (ARAY) 6.58 : Co announced that they have signed a definitive agreement to acquire Morphormics, Inc., a privately held company founded by University of North Carolina at Chapel Hill faculty members based on their research in autosegmentation of medical images. Morphormics develops medical imaging software systems that automatically recognize and extract anatomical structures from medical images. The agreement provides that Accuray will pay approximately $5.7 million.

Accuray announced it is on track to meet or exceed integration success metrics and expecting near-term return to profitability (ARAY) 5.97 : As part of Accuray's transformative acquisition of TomoTherapy Incorporated on June 10, 2011, the co set forth success metrics. In addition to reiterating the co's plans to return to profitability by the end of fiscal year 2013, which ends June 30, 2013, Accuray provided additional milestones for its fiscal year 2013. These included enhanced revenue growth, beyond the maintained or modestly increased revenue the co committed to for fiscal 2012. Specific guidance for fiscal year 2013 will be announced during Accuray's earnings call for the results for 4th quarter of fiscal 2012, but the co intends to focus on maximizing product sales through continued product innovation and market penetration. Co also anticipates further service gross margin improvements reaching 20-22 percent for the full fiscal year 2013, which is higher than originally announced.

8:49AM On The Wires (WIRES) :Accuray (ARAY) announced the extension of Emerald Service Program for the TomoTherapy System. Co will now interact directly with TomoTherapy customers in Japan